Assesment for Sleep in Myotonic Dystrophy type 1(MD-1) patients

Autor: Lorea Martinez Indart, Sandra Pedrero Tejada, Valentin Cabriada Nuño, Pilar Marin Fernandez, Sonia Castro Quintas, Beatriz Gonzalez Quero, Amaia Urrutia Gajate, Idoia Salinas Garrido, Borja Ortiz De Urbina Antia
Rok vydání: 2018
Předmět:
Zdroj: Sleep and control of breathing.
DOI: 10.1183/13993003.congress-2018.pa2553
Popis: Sleep-Disordered Breathing in MD-1 patients are common:obstructive sleep apnea (OSA), central apneas and nocturnal hypoventilacion Aim: To determine whether there is a relationship between sleep breathing disorders and clinical parameters such as symptoms of OSA, pulmonary function and degree of neuromuscular impairment Methods: Retrospective descriptive study of MD-1patients. We collected:symptoms of OSA and/or nocturnal hypoventilation, spirometry, arterial blood gases and muscle pressures and sleep test results. We analyzed the factors related to the presence of moderate OSA (AHI >15) Results: Patient´s characteristics in figure1.47patients(51%men /49%women), mean age 47.8 with BMI ≥30 in 27.7%. Only 36% reported any symptoms of OSA and/or nocturnal hypoventilation. 87% presented an AHI>5, with central apnea predominance in 44%. Factors related to AHI>15 are presented in figure2. A low nocturnal SATO2, with a CT90>10% was related to have an AHI >15. No differences were found in age, sex, obesity, OSA symptoms, pCO2 levels or functional parameters (FVC, MIP, MEP). Conclusions: 1)OSA is very common in MD1, with a high number of central apneas.2)It cannot be predicted on the symptoms, functional respiratory test or diurnal hypercapnia.3)Having a low nocturnal SATO2 and a CT 90> 10% are related to an IAH>15.4)So, we believe that nocturnal oximetry can have an important role in determining when to perform a sleep test, which will be preferably a PSG with capnography
Databáze: OpenAIRE